CARLSBAD, Calif – The popular business and marketing intelligence resource MedTech Strategist published an overview article in their May 29th issue titled, “ChromaCode Disrupts Molecular Diagnostics in the Digital Age.” The article covers how, by applying digital signal processing (DSP) tools to clinical diagnostics, ChromaCode’s CTO and HDPCR inventor, Aditya Rajagopal, married cloud-based computing to wet lab techniques to redefine the molecular multiplexing market.
The article describes the targeted mid-plex market, the competitive landscape and how the principles of ChromaCode’s high-definition PCR technology make it a compelling, low-cost alternative for clinical laboratories.